港股異動丨知行科技放量大漲,股價創逾1個月新高
智駕核心零部件供應商知行科技(1274.HK)今日盤中放量上漲,一度漲11.45%報16.16港元,創4月2日以來新高,截至目前成交額放大至1.2億港元。消息面上,今年上海車展上,知行科技與馬來西亞頭部汽車零部件供應商Delloyd簽署合作框架協議,雙方將基於各自在技術、產品和市場領域的優勢資源,在生產和銷售領域展開深入合作,共同推進包括組合輔助駕駛在內的多種智能化產品在馬來西亞,乃至東南亞市場的發展。數據顯示,2024年,知行科技交付22.7萬套智駕方案,創下同比75%的增速,全年獲得包括吉利汽車、極星、奇瑞汽車、東風汽車等知名OEM客戶及數個造車新勢力的35個新定點函,累計獲得65個定點函,全年訂單蓄水池再次擴張。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.